©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessOsteogenesis imperfecta, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Osteogenesis imperfecta comprising 16 guideline-curated and altogether 39 curated genes according to the clinical signs

ID
OP0100
Number of genes
33 Accredited laboratory test
Examined sequence length
28,9 kb (Core-/Core-canditate-Genes)
66,2 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Material
  • EDTA-anticoagulated blood (3-5 ml)
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
BMP12961NM_006129.5AR
COL1A14395NM_000088.4AD
COL1A24101NM_000089.4AD
CREB3L11560NM_052854.4AD
CRTAP1206NM_006371.5AR
FKBP101749NM_021939.4AR
IFITM5399NM_001025295.3AD
P3H12211NM_022356.4AR
P4HB1540NM_000918.4AD
PLOD22277NM_182943.3AR
PPIB651NM_000942.5AD
SERPINF11257NM_002615.7AR
SERPINH11257NM_001235.5AR
SP71296NM_001173467.3AR
TMEM38B876NM_018112.3AD
WNT11113NM_005430.4AD, AR
ALPL1575NM_000478.6AD, AR
B3GALT6990NM_080605.4AR
B4GALT7984NM_007255.3AR
CASR3237NM_000388.4AD, AR
COPB22743NM_004766.3AR
GORAB1185NM_152281.3AR
LRP54848NM_002335.4AD, AR
MBTPS21560NM_015884.4XLR
MESD705NM_015154.3AR
NBAS7116NM_015909.4AR
NUDT6951NM_007083.5AR
PLS31893NM_005032.7XL
SEC24D3099NM_014822.4AD
SPARC1037NM_003118.4AR
TAPT11745NM_153365.3AR
TENT5A1368NM_017633.3AR
TRPV62313NM_018646.6AR

Informations about the disease

Clinical Comment

Osteogenesis imperfecta (OI) comprises a heterogeneous group of genetic disorders with increased bone fragility, low bone mass and susceptibility to fractures of varying degrees of severity, sometimes even prenatally. At least 20 forms of OI are recognised and several types are distinguished by their symptoms, although characteristic features also overlap. Increasingly, mutated genes are used to define rarer OI forms. Type I is the mildest form and is known as classical non-deforming OI with blue sclerae. Type II (also known as perinatal lethal) is the most severe form. Other forms, including types III (progressively deforming OI) and IV (frequent variable OI with normal sclerae), have symptoms that lie between the above extremes. In addition to all classic hereditary forms (with variable expressivity), some of the most severe OI forms also or only after sporadic new mutations. Mutations in the COL1A1 (5-70%) and COL1A2 (5-30%) genes make up by far the largest proportion of OI causes. The diagnostic yield of OI is very high, especially with a large panel 98% and more clear diagnostic statements can be achieved.

Reference: https://www.ncbi.nlm.nih.gov/books/NBK1295/

https://www.ncbi.nlm.nih.gov/books/NBK540447/

 

Synonyms
  • Alias: Brittle bone disease
  • Alias: Glass bone disease
  • Alias: Lobstein disease
  • Alias: Osteopsathyrosis
  • Allelic: Bone mineral density variability 1 (LRP5)
  • Allelic: Bone mineral density variation QTL, osteoporosis (COL1A1)
  • Allelic: Deafness, AD 39, with dentinogenesis (DSPP)
  • Allelic: Exudative vitreoretinopathy 4 (LRP5)
  • Allelic: Hyperostosis, endosteal (LRP5)
  • Allelic: IFAP syndrome with/-out BRESHECK syndrome (MBTPS2)
  • Allelic: Keratosis follicularis spinulosa decalvans, XL (MBTPS2)
  • Allelic: Microcephaly 19, primary, AR (COPB2)
  • Allelic: Olmsted syndrome, XL (MBTPS2)
  • Allelic: Osteopenia [panelapp] (SUCO)
  • Allelic: Osteoporosis (LRP5)
  • Allelic: Osteoporosis, early-onset, susceptibility to, AD (WNT1)
  • Allelic: Osteoporosis-pseudoglioma syndrome (LRP5)
  • Allelic: Osteosclerosis (LRP5)
  • Allelic: Polycystic liver disease 4 with/-out kidney cysts (LRP5)
  • Allelic: Preterm premature rupture of the membranes, susceptibility to (SERPINH1)
  • Allelic: Skeletal dysplasia [HP:0002652, panelapp] (SUCO)
  • Allelic: Skeletal dysplasias [panelapp] (NOTCH2)
  • Allelic: van Buchem disease, type 2 (LRP5)
  • Bruck syndrome 1 (FKBP10)
  • Caffey disease (COL1A1)
  • Cole-Carpenter syndrome 1 (P4HB)
  • Dentin dysplasia, type II (DSPP)
  • Dentinogenesis imperfecta, Shields type II (DSPP)
  • Dentinogenesis imperfecta, Shields type III (DSPP)
  • Ehlers-Danlos syndrome, arthrochalasia type, 1 (COL1A1)
  • Ehlers-Danlos syndrome, arthrochalasia type, 2 (COL1A2)
  • Ehlers-Danlos syndrome, cardiac valvular type (COL1A2)
  • Hyperparathyroidism, transient neonatal (TRPV6)
  • Microcephaly 19, primary, AR (COPB2)
  • No fracture [panelapp] (DSPP)
  • Osteochondrodysplasia, complex lethal, Symoens-Barnes-Gistelinck type (TAPT1)
  • Osteogenesis imperfecta + decreased bone density [panelapp] (NOTCH2)
  • Osteogenesis imperfecta [MONDO:0019019, panelapp] (SUCO)
  • Osteogenesis imperfecta, type I-IV (COL1A1)
  • Osteogenesis imperfecta, type II-IV (COL1A2)
  • Osteogenesis imperfecta, type V (IFITM5)
  • Osteogenesis imperfecta, type VI (SERPINF1)
  • Osteogenesis imperfecta, type VII (CRTAP)
  • Osteogenesis imperfecta, type VIII (P3H1 syn. LEPRE1)
  • Osteogenesis imperfecta, type X (SERPINH1)
  • Osteogenesis imperfecta, type XI (FKBP10)
  • Osteogenesis imperfecta, type XII (SP7)
  • Osteogenesis imperfecta, type XIII (BMP1)
  • Osteogenesis imperfecta, type XIV (TMEM38B)
  • Osteogenesis imperfecta, type XIX (MBTPS2)
  • Osteogenesis imperfecta, type XV (WNT1)
  • Osteogenesis imperfecta, type XVI (CREB3L1)
  • Osteogenesis imperfecta, type XVII (SPARC)
  • Osteogenesis imperfecta, type XVIII (TENT5A syn. FAM46A)
  • Osteogenesis imperfecta, type XX (MESD)
  • Osteogenesis imperfecta, type XXI (KDELR2)
  • Osteootohepatoenteric syndrome (UNC45A)
  • Osteopetrosis, AD 1 (LRP5)
  • Osteoporosis, childhood- or juvenile-onset, with developmental delay (COPB2)
  • Osteoporosis, postmenopausal (COL1A2)
  • Recurr. fractures, add. skelet. signs, short-limb dwarfism, bowed legs, scoliosis [panelapp] (NUDT6)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

No text defined